ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,069Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 300

$347K Total Retail Price of All Prescriptions

Rank: 64 out of 300

449 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 6,620 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCHLOROTHIAZIDE 363 286 1 20
LISINOPRIL 346 295 2 4
AMLODIPINE BESYLATE 303 257 3 2
METFORMIN HCL 285 223 4 19
METOPROLOL TARTRATE 278 251 5 13
FUROSEMIDE 259 228 6 3
PRAVASTATIN SODIUM 196 180 7 15
LEVOTHYROXINE SODIUM 180 169 8 9
LOVASTATIN 145 141 9 68
WARFARIN SODIUM 142 124 10 10
LOSARTAN POTASSIUM 138 126 11 29
ATORVASTATIN CALCIUM 136 107 12 14
NEXIUM 131 88 13 17
TRAMADOL HCL 129 108 14 23
METOPROLOL SUCCINATE 123 112 15 6
SIMVASTATIN 116 71 16 5
ZOLPIDEM TARTRATE 105 87 17 21
ATENOLOL 103 87 18 31
MELOXICAM 99 72 19 27
DIGOXIN 93 79 20 39
HYDROCODONE-ACETAMINOPHEN 89 67 S3 21 1
GABAPENTIN 78 62 22 7
OMEPRAZOLE 76 69 23 11
CLOPIDOGREL 73 68 24 18
CIPROFLOXACIN HCL 71 61 25 28
POTASSIUM CHLORIDE 71 70 25 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 46 27 64
GEMFIBROZIL 69 49 28 186
PREDNISONE 68 64 29 33
LANTUS 65 59 30 125
PANTOPRAZOLE SODIUM 65 55 30 35
CAPTOPRIL 63 63 32 270
ALLOPURINOL 63 61 32 44
PLAVIX 63 63 32 24
GLYBURIDE-METFORMIN HCL 58 44 R 35 203
GLIPIZIDE 58 58 35 184
DIOVAN 56 23 37 46
CRESTOR 55 50 38 26
NIFEDIPINE ER 54 54 39 120
COMBIVENT 52 47 40 218
AZITHROMYCIN 52 38 40 72
RANITIDINE HCL 51 45 42 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.